Search

Search Constraints

You searched for: Author/Creator Singhi, A.

Search Results

5. Neoadjuvant Chemotherapy Resulting in Suboptimal CA19-9 Response is Associated with No Survival Benefit Compared to Surgery First Approach in Resectable or Borderline Resectable Pancreatic Cancer. (2022)

7. Presence of perineural invasion determines the need for adjuvant chemotherapy in resected pancreatic carcinoma with node negative disease following neoadjuvant therapy; a multi-institutional analysis. (2021)